Status:
COMPLETED
Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients
Lead Sponsor:
Danish Headache Center
Conditions:
Headache
Migraine
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
To investigate the role of KATP channels in migraine with aura patients.
Eligibility Criteria
Inclusion
- Migraine with aura patients of both sexes.
- 18-60 years.
- 50-100 kg.
Exclusion
- Headache less than 48 hours before the tests start
- Daily consumption of drugs of any kind other than oral contraceptives
- Pregnant or nursing women.
- Cardiovascular disease of any kind, including cerebrovascular diseases.
Key Trial Info
Start Date :
July 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2019
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04012047
Start Date
July 9 2019
End Date
December 10 2019
Last Update
March 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish headache center
Glostrup Municipality, Denmark, 2600